Stock TOVX THERIVA BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Theriva Biologics, Inc.

Equities

TOVX

US87164U4094

Market Closed - Nyse
Other stock markets
 04:10:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.42 USD +0.12% Intraday chart for Theriva Biologics, Inc. +2.19% -2.35%
Apr. 23 Theriva Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma CI
Mar. 25 Transcript : Theriva Biologics, Inc., 2023 Earnings Call, Mar 25, 2024

Evolution of the average Target Price on Theriva Biologics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7113edfea406511ded4d.c5BD5EsQUPfXtEUKSHi2hULqbRmKqP15_xe7KsfQ_Ew.GOQynRlJPsO41nFDP0vOwiqLAy7uxKImlG3jEr7mszw81yyAG0kfseXmMg~298b5407cd774d84f4082dcf61f46dc9

Analyst Recommendations on Theriva Biologics, Inc.

Cantor Fitzgerald Initiates Coverage on Synthetic Biologics With Overweight Rating MT
History shows stocks can weather rate hike cycle RE
SYNTHETIC BIOLOGICS : Maxim Upgrades Synthetic Biologics to Buy From Hold; Price Target is $2.50 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.42 USD
Average target price
4.5 USD
Spread / Average Target
+971.43%
High Price Target
7 USD
Spread / Highest target
+1,566.67%
Low Price Target
2 USD
Spread / Lowest Target
+376.19%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Theriva Biologics, Inc.

Cantor Fitzgerald
Maxim

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. TOVX Stock
  4. Consensus Theriva Biologics, Inc.